|
Volumn 367, Issue 9505, 2006, Pages 87-88
|
Stem-cell therapy after acute myocardial infarction: The focus should be on those at risk
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
BLOOD FLOW;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
HEART EJECTION FRACTION;
HEART FUNCTION;
HEART INFARCTION;
HEART MUSCLE;
HEART VENTRICLE FUNCTION;
HUMAN;
NOTE;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
REPERFUSION;
ST SEGMENT ELEVATION;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
|
EID: 30444460254
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)67895-6 Document Type: Note |
Times cited : (36)
|
References (8)
|